SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-001379
Filing Date
2021-08-12
Accepted
2021-08-12 16:37:33
Documents
61
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sbtx-20210630.htm   iXBRL 10-Q 2069457
2 EX-31.1 sbtx-20210630ex31_1.htm EX-31.1 17454
3 EX-31.2 sbtx-20210630ex31_2.htm EX-31.2 17443
4 EX-32.1 sbtx-20210630ex32_1.htm EX-32.1 21979
5 GRAPHIC img238294234_0.jpg GRAPHIC 87656
  Complete submission text file 0000950170-21-001379.txt   6067277

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sbtx-20210630_cal.xml EX-101.CAL 28915
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sbtx-20210630.xsd EX-101.SCH 35316
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sbtx-20210630_pre.xml EX-101.PRE 226599
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sbtx-20210630_lab.xml EX-101.LAB 300090
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sbtx-20210630_def.xml EX-101.DEF 120486
11 EXTRACTED XBRL INSTANCE DOCUMENT sbtx-20210630_htm.xml XML 821826
Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Filer) CIK: 0001671858 (see all company filings)

IRS No.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39756 | Film No.: 211168213
SIC: 2834 Pharmaceutical Preparations